Literature DB >> 35622261

Morphofunctional Characteristics of Erythrocytes and Blood Erythropoietin Level in Patients as Predictors of Severe Course of COVID-19.

V V Revin1, L A Balykova1, O A Radaeva1, V V Shchapov1,2, E S Revina1, S I Pinyaev1, Yu A Kostina1, E D Kozlov3.   

Abstract

Morphological and functional characteristics of erythrocytes, hemoglobin, and erythropoietin level in the venous blood were evaluated by laser interference microscopy, Raman spectroscopy with a short-focus extreme aperture lens monochromator, and by ELISA, respectively, in 30 patients with verified moderate COVID-19 at the time of hospitalization and 30 healthy volunteers. The patients whose course of COVID-19 has worsened to critical by day 5 had already had lower (p<0.001) indicators at the time of hospitalization such as the area and thickness of erythrocytes, the hemoglobin distribution and packing density, hemoglobin conformation index (I1355/I1550)/(I1375/I1580) reflecting its oxygen affinity, and blood erythropoietin content. Our findings suggest that these characteristics of erythrocytes, hemoglobin, and erythropoietin can serve as potential predictors of COVID-19 aggravation in hospitalized patients.
© 2022. Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  COVID-19; erythrocytes; erythropoietin; hemoglobin; worsening course markers

Mesh:

Substances:

Year:  2022        PMID: 35622261      PMCID: PMC9136801          DOI: 10.1007/s10517-022-05490-7

Source DB:  PubMed          Journal:  Bull Exp Biol Med        ISSN: 0007-4888            Impact factor:   0.737


  11 in total

1.  Chronic IFN-γ production in mice induces anemia by reducing erythrocyte life span and inhibiting erythropoiesis through an IRF-1/PU.1 axis.

Authors:  Sten F Libregts; Laura Gutiérrez; Alexander M de Bruin; Felix M Wensveen; Petros Papadopoulos; Wilfred van Ijcken; Zeliha Ozgür; Sjaak Philipsen; Martijn A Nolte
Journal:  Blood       Date:  2011-07-01       Impact factor: 22.113

Review 2.  Erythropoetin as a novel agent with pleiotropic effects against acute lung injury.

Authors:  Sotirios Kakavas; Theano Demestiha; Panagiotis Vasileiou; Theodoros Xanthos
Journal:  Eur J Clin Pharmacol       Date:  2010-11-11       Impact factor: 2.953

3.  In vivo suppression of erythropoiesis by tumor necrosis factor-alpha (TNF-alpha): reversal with exogenous erythropoietin (EPO).

Authors:  C S Johnson; C A Cook; P Furmanski
Journal:  Exp Hematol       Date:  1990-02       Impact factor: 3.084

4.  Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China.

Authors:  Chaomin Wu; Xiaoyan Chen; Yanping Cai; Jia'an Xia; Xing Zhou; Sha Xu; Hanping Huang; Li Zhang; Xia Zhou; Chunling Du; Yuye Zhang; Juan Song; Sijiao Wang; Yencheng Chao; Zeyong Yang; Jie Xu; Xin Zhou; Dechang Chen; Weining Xiong; Lei Xu; Feng Zhou; Jinjun Jiang; Chunxue Bai; Junhua Zheng; Yuanlin Song
Journal:  JAMA Intern Med       Date:  2020-07-01       Impact factor: 21.873

5.  Red cell distribution width is associated with mortality in non-anemic patients with COVID-19.

Authors:  Joseph L Rapp; Douglas Tremblay; Naomi Alpert; Wil Lieberman-Cribbin; John Mascarenhas; Emanuela Taioli; Saghi Ghaffari
Journal:  J Med Virol       Date:  2021-04-23       Impact factor: 2.327

6.  Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study.

Authors:  George Goshua; Alexander B Pine; Matthew L Meizlish; C-Hong Chang; Hanming Zhang; Parveen Bahel; Audrey Baluha; Noffar Bar; Robert D Bona; Adrienne J Burns; Charles S Dela Cruz; Anne Dumont; Stephanie Halene; John Hwa; Jonathan Koff; Hope Menninger; Natalia Neparidze; Christina Price; Jonathan M Siner; Christopher Tormey; Henry M Rinder; Hyung J Chun; Alfred I Lee
Journal:  Lancet Haematol       Date:  2020-06-30       Impact factor: 18.959

7.  The relationship between serum erythropoietin, hepcidin, and haptoglobin levels with disease severity and other biochemical values in patients with COVID-19.

Authors:  Sema Yağcı; Erdinç Serin; Özlem Acicbe; Mustafa İsmet Zeren; Merve Sena Odabaşı
Journal:  Int J Lab Hematol       Date:  2021-02-07       Impact factor: 3.450

Review 8.  A Perspective on Erythropoietin as a Potential Adjuvant Therapy for Acute Lung Injury/Acute Respiratory Distress Syndrome in Patients with COVID-19.

Authors:  Adeleh Sahebnasagh; Mojataba Mojtahedzadeh; Farhad Najmeddin; Atabak Najafi; Mohammadreza Safdari; Hassan Rezai Ghaleno; Solomon Habtemariam; Ioana Berindan-Neagoe; Seyed Mohammad Nabavi
Journal:  Arch Med Res       Date:  2020-08-11       Impact factor: 2.235

9.  Hemoglobin value may be decreased in patients with severe coronavirus disease 2019.

Authors:  Giuseppe Lippi; Camilla Mattiuzzi
Journal:  Hematol Transfus Cell Ther       Date:  2020-04-02

10.  Evidence of Structural Protein Damage and Membrane Lipid Remodeling in Red Blood Cells from COVID-19 Patients.

Authors:  Tiffany Thomas; Davide Stefanoni; Monika Dzieciatkowska; Aaron Issaian; Travis Nemkov; Ryan C Hill; Richard O Francis; Krystalyn E Hudson; Paul W Buehler; James C Zimring; Eldad A Hod; Kirk C Hansen; Steven L Spitalnik; Angelo D'Alessandro
Journal:  J Proteome Res       Date:  2020-10-26       Impact factor: 4.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.